Addressing the burden of mental, neurological, and substance use disorders: Key messages from Disease Control Priorities, 3rd edition

The Lancet

Volumn 387, Issue 10028, 2016, Pages 1672-1685

  Patel, Vikram ^a,b,c   Chisholm, Dan ^d   Parikh, Rachana ^b   Charlson, Fiona J ^e,f,g   Degenhardt, Louisa ^g,h,i   Dua, Tarun ^d   Ferrari, Alize J ^e,f,g   Hyman, Steve ^k   Laxminarayan, Ramanan ^b,l,m   Levin, Carol ⁿ   Lund, Crick ^o,u   Medina Mora, María Elena ^p   Petersen, Inge ^q   Scott, James ^e,r   Shidhaye, Rahul ^b,s   Vijayakumar, Lakshmi ^j,t   Thornicroft, Graham ^u   Whiteford, Harvey ^e,g  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^c Sangath   (India)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f Queensland Centre for Mental Health Research   (Australia)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k Harvard University   (United States)

^l Economics and Policy   (United States)

^m PRINCETON UNIVERSITY   (United States)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o UNIVERSITY OF CAPE TOWN   (South Africa)

^p National Institute of Health Psychiatry Ramón de la Fuente Muñíz   (Mexico)

^q UNIVERSITY OF KWAZULU NATAL   (South Africa)

^r ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^s MAASTRICHT UNIVERSITY   (Netherlands)

^t SNEHA   (India)

^u KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUPRENORPHINE; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; MEMANTINE; METHADONE; METHYLPHENIDATE; MOOD STABILIZER; NALTREXONE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENYTOIN; PROPRANOLOL; VALPROIC ACID;

ALCOHOLISM; ANXIETY DISORDER; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISABILITY; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; FINANCIAL MANAGEMENT; GENERAL PRACTICE; GOVERNMENT; HEALTH; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH SERVICE; HOSPITAL CARE; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; MENTAL DISEASE; MENTAL HEALTH CARE; MENTAL PATIENT; MENTAL, NEUROLOGICAL AND SUBSTANCE USE DISORDER; MULTICENTER STUDY (TOPIC); NEUROLOGIC DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOTHERAPY; PUBLIC HEALTH; RESOURCE ALLOCATION; REVIEW; SCALE UP; STIGMA; SUBSTANCE ABUSE; SUICIDE; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; INSURANCE; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; ORGANIZATION AND MANAGEMENT; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

COST OF ILLNESS; DELIVERY OF HEALTH CARE; GLOBAL HEALTH; HEALTH CARE COSTS; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; SUBSTANCE-RELATED DISORDERS; UNIVERSAL COVERAGE;

EID: 84962942604     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00390-6     Document Type: Review

References (46)

1. DT Jamison Disease Control Priorities, 3rd edition: improving health and reducing poverty Lancet 2015 published online Feb 5. http://dx.doi.org/10.1016/S0140-6736(15)60097-6
2. V Patel, C Lund, S Heatherill et al. Social determinants of mental disorders E Blas A Sivasankara Kurup Priority public health conditions: from learning to action on social determinants of health 2009 World Health Organization Geneva
3. C Lund, M De Silva, S Plagerson et al. Poverty and mental disorders: breaking the cycle in low-income and middle-income countries Lancet 378 2011 1502 1514
4. WHO Mental Health Gap Action Programme (mhGAP): scaling up care for mental, neurological and substance abuse disorders 2008 World Health Organization Geneva
5. HA Whiteford, L Degenhardt, J Rehm et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 Lancet 382 2013 1575 1586
6. AJ Ferrari, RE Norman, G Freedman et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010 PLoS One 9 2014 e91936
7. HA Whiteford, AJ Ferrari, L Degenhardt, V Feigin, T Vos The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010 PLoS One 10 2015 e0116820
8. CK Chang, RD Hayes, G Perera et al. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London PLoS One 6 2011 e19590
9. D Lawrence, KJ Hancock, S Kisely The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers BMJ 346 2013 f2539
10. ER Walker, RE McGee, BG Druss Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis JAMA Psychiatry 72 2015 334 341
11. A Flaxman, T Vos, C Murray An integrative metaregression framework for descriptive epidemiology 2015 University of Washington Press Seattle
12. SS Lim, T Vos, AD Flaxman et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2224 2260
13. DE Bloom, ET Cafiero, E Jane-Llopis et al. The global economic burden of non-communicable diseases 2011 World Economic Forum Geneva
14. J Rehm, C Mathers, S Popova, M Thavorncharoensap, Y Teerawattananon, J Patra Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders Lancet 373 2009 2223 2233
15. WHO Dementia: A Public Health Priority 2012 World Health Organization Geneva
16. V Patel, A Kleinman, B Saraceno Protecting the human rights of people with mental disorders: a call to action for global mental health M Dudley D Silove F Gale Mental health and human rights 2012 Oxford University Press Oxford
17. V Chandra, R Pandav, R Laxminarayan et al. Neurological disorders DT Jamison JG Breman AR Measham Disease control priorities in developing countries 2nd edn. 2006 World Bank Washington, DC
18. S Hyman, D Chisholm, R Kessler, V Patel, H Whiteford Mental disorders DT Jamison JG Breman AR Measham Disease control priorities in developing countries 2006 World Bank Washington, DC
19. J Rehm, D Chisholm, R Room, AD Lopez Alcohol DT Jamison JG Breman AR Measham Disease control priorities in developing countries 2nd edn. 2006 World Bank Washington, DC
20. T Dua, C Barbui, N Clark et al. Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations PLoS Med 8 2011 e1001122
21. J Strang, T Babor, J Caulkins, B Fischer, D Foxcroft, K Humphreys Drug policy and the public good: evidence for effective interventions Lancet 379 2012 71 83
22. N van Ginneken, P Tharyan, S Lewin et al. Non-specialist health worker interventions for the care of mental, neurological and substance-abuse disorders in low- and middle-income countries Cochrane Database Syst Rev 11 2013 CD009149.
23. D Chisholm, S Saxena Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and south east Asia: mathematical modelling study BMJ 344 2012 e609
24. NK Aggarwal, M Balaji, S Kumar et al. Using consumer perspectives to inform the cultural adaptation of psychological treatments for depression: a mixed methods study from south Asia J Affect Disord 163 2014 88 101
25. B Saraceno, M van Ommeren, R Batniji et al. Barriers to improvement of mental health services in low-income and middle-income countries Lancet 370 2007 1164 1174
26. V Patel, GS Belkin, A Chockalingam, J Cooper, S Saxena, J Unutzer Integrating mental health services into priority health care platforms: addressing a grand challenge in global mental health PLoS Med 10 2013 e1001448
27. VK Ngo, A Rubinstein, V Ganju et al. Grand challenges: integrating mental health care into the non-communicable disease agenda PLoS Med 10 2013 e1001443
28. A Rahman, PJ Surkan, CE Cayetano, P Rwagatare, KE Dickson Grand challenges: integrating maternal mental health into maternal and child health programmes PLoS Med 10 2013 e1001442
29. S Kaaya, E Eustache, I Lapidos-Salaiz, S Musisi, C Psaros, L Wissow Grand challenges: improving HIV treatment outcomes by integrating interventions for co-morbid mental illness PLoS Med 10 2013 e1001447
30. H Ma Integration of hospital and community services - the '686 Project' - is a crucial component in the reform of China's mental health services Shanghai Arch Psychiatry 24 2012 172 174
31. WHO Building back better: sustainable mental health care after emergencies 2013 World Health Organization Geneva
32. D Gunnell, R Fernando, M Hewagama, WD Priyangika, F Konradsen, M Eddleston The impact of pesticide regulations on suicide in Sri Lanka Int J Epidemiol 36 2007 1235 1242
33. WHO WHO Humanitarian response compendium of health priorities and WHO projects in consolidated appeals and response plans 2013 World Health Organization Geneva
34. B Prukkanone, T Vos, M Bertram, S Lim Cost-effectiveness analysis for antidepressants and cognitive behavioral therapy for major depression in Thailand Value Health 15 suppl 2012 S3 S8
35. O Gureje, D Chisholm, L Kola, V Lasebikan, S Saxena Cost-effectiveness of an essential mental health intervention package in Nigeria World Psychiatry 6 2007 42 48
36. LM Lindner, AC Marasciulo, MR Farias, GE Grohs Economic evaluation of antipsychotic drugs for schizophrenia treatment within the Brazilian healthcare system Rev Saude Publica 43 suppl 1 2009 62 69
37. P Anderson, D Chisholm, DC Fuhr Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol Lancet 373 2009 2234 2246
38. D Chisholm, AE Stanciole, T Tan Torres Edejer, DB Evans Economic impact of disease and injury: counting what matters BMJ 340 2010 c924
39. Chisholm DJ, Raykar KA, Meggido N, et al. Universal health coverage for mental, neurological, and substance use disorders: an extended cost-effectiveness analysis. In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina Mora ME, eds. Disease Control Priorities (3rd edn). Volume 4: mental, neurological, and substance use disorders.
40. S Saxena, G Thornicroft, M Knapp, H Whiteford Resources for mental health: scarcity, inequity, and inefficiency Lancet 370 2007 878 889
41. Lancet Global Mental Health Group Scale up services for mental disorders: a call for action Lancet 370 2007 1241 1252
42. BJ Gilbert, V Patel, PE Farmer, C Lu Assessing development assistance for mental health in developing countries: 2007-2013 PLoS Med 12 2015 e1001834
43. WHO Mental health atlas 2014 2015 World Health Organization Geneva
44. S Saxena, M Funk, D Chisholm World Health Assembly adopts Comprehensive Mental Health Action Plan 2013-2020 Lancet 381 2013 1970 1971
45. R Gater, K Saeed, A Rahman From plan to framework: the process followed in the development of the regional framework for scaling up action on mental health towards the implementation of the Comprehensive Mental Health Action Plan 2013-2020 in the Eastern Mediterranean Region East Mediterr Health J 21 2015 464 466
46. V Patel, B Saraceno, A Kleinman Beyond evidence: the moral case for international mental health Am J Psychiatry 163 2006 1312 1315